TheEdgeResearch
Home / Stocks / SHPH

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
$3.49 ▼ -10.51%
Market Cap
$16.6M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.14
52-Wk Range
2.576-44.4
CEO
Christopher Robert Cooper
Country
US
Currency
USD

Shuttle Pharmaceuticals Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Gaithersburg, MD, US. The stock last traded at $3.49, down 10.51% on the session, giving a market capitalisation of $16.6M. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of 0.0%. Its beta of 1.14 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.11
Price / Sales
0.00
Price / Book
0.18
EV / EBITDA
-1.77
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.01
Current ratio
0.11
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
2
IPO date
2022-08-31
Headquarters
Gaithersburg, MD, US
About Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Comparable companies

Shuttle Pharmaceuticals Holdings, Inc. is most often compared with the following Healthcare names:

AKANBBLGBIVIHSCSIMCCISPCMSPRRDHLTOVXUPC
More research on SHPH
SHPH technical analysis SHPH TheEdge Score Compare against peers
Open full interactive analysis & DCF →